Responding To FDA 483s And Warning Letters: Some Dos, Don’ts And Red Flags
Executive Summary
Invalidated OOS results are ‘red flags’ during FDA inspections and ‘denying, delaying, limiting or refusing’ a drug inspection proposed by the agency could have serious consequence, participants at a recent webinar on best practices for responding to Form 483s and warnings letters heard.